Depreciation of Verrica Pharmaceuticals Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Verrica Pharmaceuticals Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Verrica Pharmaceuticals Inc. Depreciation for the quarter ending 31 Dec 2025 was $14,193, a 11% decline year-over-year.
  • Verrica Pharmaceuticals Inc. Depreciation for the twelve months ending 31 Dec 2025 was $133,000, a 61% decline year-over-year.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2025 was $133,000, a 61% decline from 2024.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2024 was $342,000, a 35% decline from 2023.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2023 was $530,000, a 17% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Verrica Pharmaceuticals Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $133,000 $14,193 -$1,807 -11% 01 Oct 2025 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q3 2025 $134,807 $21,807 -$78,193 -78% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $213,000 $45,000 -$55,000 -55% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $268,000 $52,000 -$74,000 -59% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $342,000 $16,000 -$183,000 -92% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q3 2024 $525,000 $100,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $525,000 $100,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $525,000 $126,000 -$5,000 -3.8% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $530,000 $199,000 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $100,000 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $100,000 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $131,000 +$33,000 +34% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $98,000 +$87,000 +791% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $11,000 -$3,000 -21% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $14,000 +$3,000 +27% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $11,000 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1

Verrica Pharmaceuticals Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $133,000 -$209,000 -61% 01 Jan 2025 31 Dec 2025 10-K 11 Mar 2026 2025 FY
2024 $342,000 -$188,000 -35% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2026 2025 FY
2023 $530,000 +$76,000 +17% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $454,000 +$210,000 +86% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $244,000 +$201,000 +467% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $43,000 -$21,200 -33% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2022 2021 FY
2019 $64,200 +$43,900 +216% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2021 2020 FY
2018 $20,300 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.